article_snippet.sent: A cancer patient showed a staggering response to a new combination of two drugs, to treat skin cancer.
article_snippet.sent: Scientists at the hospital have conducted a trial, treating patients diagnosed with advanced melanoma with a new type of treatment.
article_snippet.sent: Four years ago doctors removed a 4.2mm melanoma from A cancer patient back.
article_snippet.sent: Doctors treating the patient said: 'the patient had a rapid eradication of a large tumour mass after a single treatment with combination immunotherapy.'
article_snippet.sent: the patient now, no longer has any detectable melanoma. '
article_snippet.sent: The World Health Organisation estimates that worldwide there are 66,000 deaths annually from skin cancer, with approximately 80 per cent due to melanoma.
article_snippet.sent: Researchers at the Memorial Sloan-Kettering Cancer Center, led by medical oncologist Michael Postow, examined 142 patients with advanced melanoma, as part of Researchers at the Memorial Sloan-Kettering Cancer Center trials.
article_snippet.sent: The patient was treated as part of a clinical trial to test the effects of a new drugs combination on patients with advanced melanoma, pictured.
article_snippet.sent: Dr Postow said: 'The incredibly high response rate seen in this trial for patients receiving the combination - approximately 60 per cent - now lets us tell patients that patients have a high chance of significantly shrinking patients melanoma with this treatment. '
article_snippet.sent: Senior author, Jedd Wolchok, chief of the melanoma and immunotherapeutics service at Memorial Sloan-Kettering Cancer Center (MSK), said: 'Senior author, Jedd Wolchok, chief of the melanoma and immunotherapeutics service at Memorial Sloan-Kettering Cancer Center (MSK) are excited about these results and believe these results support the principle that rationally combining effective medicines is an approach to achieving better outcomes for patients.'
article_snippet.sent: Doctors at MSK helped spearhead clinical trials testing the drug's safety and effectiveness and continue to conduct studies using the drug to treat melanoma and other cancers.
highlights_snippet.sent: Doctors at Memorial Sloan Kettering Cancer Center in New York were trialling a new combination of drugs to treat advanced skin cancer .
  